New SGLT-2 inhibitor measures on OpenPrescribing and OpenPrescribing Hospitals
We have two new measures available now for SGLT-2 inhibitors.
By Vicky Speed, Chris Wood
This is a beta version of OpenPrescribing Hospitals for testing and feedback purposes. Data and functionality may be incomplete. Please contact us if you find any issues or have feedback. Sign up for email alerts to stay updated.
Blog
Latest Posts
news
OpenPrescribing Hospitals email alerts
Stay updated with notifications of new OpenPrescribing Hospitals features and data releases.
By Chris Wood, Louis Fisher, Brian MacKenna
OpenPrescribing Autumn 2025 Newsletter
This newsletter contains all the latest updates from OpenPrescribing
By Caroline Acuda, Vicky Speed
All Posts
New SGLT-2 inhibitor measures on OpenPrescribing and OpenPrescribing Hospitals
We have two new measures available now for SGLT-2 inhibitors.
By Vicky Speed, Chris Wood
news
OpenPrescribing Hospitals email alerts
Stay updated with notifications of new OpenPrescribing Hospitals features and data releases.
By Chris Wood, Louis Fisher, Brian MacKenna
OpenPrescribing Autumn 2025 Newsletter
This newsletter contains all the latest updates from OpenPrescribing
By Caroline Acuda, Vicky Speed
OpenPrescribing Hospitals: multi-product analyses
A look at how to run a multi-product analysis on OpenPrescribing Hospitals.
By Louis Fisher, Vicky Speed, Brian MacKenna
Choosing a quantity type for your analysis on OpenPrescribing Hospitals
How to choose the most appropriate quantity type for custom analyses on OpenPrescribing Hospitals.
By Louis Fisher, Brian MacKenna
OpenPrescribing Hospitals: numbers please!
A look at how to use the summary tables produced in custom analyses on OpenPrescribing Hospitals.
By Louis Fisher, Vicky Speed
OpenPrescribing Hospitals: analysing medicines usage at different organisational levels
How you can run custom analyses of variation in medicines issuing across NHS trusts, ICB, region and nationally.
By Louis Fisher, Vicky Speed, Brian MacKenna
Co-proxamol: not gone yet. What can you do?
A summary of our research letter highlighting continuing co-proxamol use, published in the British Journal of General Practice
By Brian MacKenna, Richard Croker
Analysing lithium usage in primary and secondary care
A national medicines usage analysis for lithium in primary and secondary care in England
By Hayley Schiffer
news
Lidocaine plasters measure in OpenPrescribing Hospitals
We’ve launched a new OpenPrescribing Hospitals ‘low value prescribing’ measure for lidocaine plasters.
By Chris Wood, Vicky Speed, Louis Fisher
news
OpenPrescribing Hospitals - Special Edition Newsletter
Special edition OpenPrescribing newsletter introducing our new tool, OpenPrescribing Hospitals.
By Vicky Speed, Louis Fisher
You asked: Can we monitor the usage of biosimilars in secondary care using OpenPrescribing Hospitals?
What are biosimilars, why are they of interest and why can we monitor usage with primary care data but not secondary care data?
By Vicky Speed, Brian MacKenna
OpenPrescribing Hospitals Product Lookup
A look at the new Product Lookup feature on OpenPrescribing Hospitals
By Louis Fisher, Vicky Speed
Calculating Defined Daily Dose quantity in the Secondary Care Medicines Data
What is a Defined Daily Dose, how can they calculated from the quantity reported in the Secondary Care Medicines Data, and why are they useful?
By Louis Fisher, Chris Wood
Classifying and measuring medicines usage with the ATC/DDD system
How the ATC can be used to classify medications and how DDs can be used to measure their usage.
By Louis Fisher, Chris Wood, Brian MacKenna
Calculating ingredient quantity in the Secondary Care Medicines Data
What is ingredient quantity, how can it be calculated from the quantity reported in the Secondary Care Medicines Data, and why is it useful?
By Louis Fisher, Chris Wood, Vicky Speed
OpenPrescribing Hospitals Meets the Public
Brian MacKenna demonstrated OpenPrescribing Hospitals at the 2025 Clinical Pharmacy Congress last month. Here’s his thoughts on how it went.
By Brian MacKenna
Calculating unit dose quantity in the Secondary Care Medicines Data
What are unit doses, how can they be calculated from the quantity reported in the Secondary Care Medicines Data, and why are they useful?
By Louis Fisher, Chris Wood, Andrew Brown
Measuring quantity in the Secondary Care Medicines Data
A look at how quantity is measured in the Secondary Care Medicines Data
By Louis Fisher, Chris Wood
Custom analyses on OpenPrescribing Hospitals
The new custom analysis feature on OpenPrescribing Hospitals.
By Louis Fisher, Brian MacKenna
Low value medicines in OpenPrescribing Hospitals
How we can use OpenPrescribing Hospitals measures to look at use of low value medicines in hospitals.
By Chris Wood, Louis Fisher, Steve Black, Brian MacKenna
Highlighting variation in hospitals medicines usage
How we highlight variation in hospital medicines usage in OpenPrescribing Hospitals Measures.
By Chris Wood, Louis Fisher, Steve Black, Brian MacKenna
Introducing OpenPrescribing Hospitals measures
An introduction to a new measures tool in OpenPrescribing Hospital.
By Chris Wood, Louis Fisher, Steve Black, Brian MacKenna
Improvements to how the Secondary Care Medicines Data is published
The way the Secondary Care Medicines Data is published has recently changed. This is why this is good news for OpenPrescribing Hospitals.
By Louis Fisher, Steve Black, Brian MacKenna
Getting more from the Secondary Care Medicines Data using the dictionary of medicines and devices
How we can make it easier to compare issuing quantities of different products within the Secondary Care Medicines Data by using the dictionary of medicines and devices to find more …
By Louis Fisher, Chris Wood, Steve Black, Brian MacKenna
Show me the data! What does the Secondary Care Medicines Data look like?
A first look at the data within the Secondary Care Medicines Dataset.
By Louis Fisher, Steve Black, Brian MacKenna, Chris Wood
news
OpenPrescribing Hospitals - now live, and open for your feedback
We’ve made OpenPrescribing Hospitals platform to all with our first feature. Read more to see how you can access it.
By Giles Turnbull, Louis Fisher, Brian MacKenna
More about hospital stock control data
A deeper dive into what stock control data is and how it impacts the way the SCMD is published
By Louis Fisher, Steve Black, Brian MacKenna, Vicky Speed
Understanding the Secondary Care Medicines Dataset
A brief description of the Secondary Care Medicines Dataset, the primary dataset used in OpenPrescribing Hospitals
By Louis Fisher, Steve Black, Vicky Speed
data-exploration
data-quality
organisations
features
OpenPrescribing Hospitals Submission history: showing the gaps in hospital medicines data
An explanation of the Submission History feature on OpenPrescribing Hospitals
By Louis Fisher, Steve Black, Vicky Speed, Brian MacKenna, Chris Wood
data-exploration
data-quality
organisations
Organising Organisations: Data consistency
The third blog in the series: Organising Organisations. Here, we describe how consistent the data submitted by NHS Trusts to the Secondary Care Medicines Dataset is
By Louis Fisher, Steve Black, Vicky Speed, Brian MacKenna
data-exploration
data-quality
organisations
Organising Organisations: Data completeness
The second blog in the series: Organising Organisations. Here, we describe how complete the data submitted by NHS Trusts to the Secondary Care Medicines Dataset is
By Louis Fisher, Steve Black, Vicky Speed, Brian MacKenna
data-exploration
data-quality
organisations
Organising Organisations: Hospital Trusts in OpenPrescribing Hospitals
The first blog in the series: Organising Organisations. Here, we describe which NHS Trusts are included in the Secondary Care Medicines Dataset and how they can be identified
By Louis Fisher, Steve Black, Vicky Speed, Brian MacKenna
data-exploration
data-quality
organisations
features
We're going to build OpenPrescribing for hospitals: here's why
We’re going to build OpenPrescribing for hospitals using openly available secondary care medicines data. Here we explain why and what you can expect.
By Vicky Speed, Steve Black, Louis Fisher
news
Exciting new developments with hospital medicines data
We briefly summarise all the recent big and exciting developments in hospital medicines data.
By Brian MacKenna, Vicky Speed